0082 Suppl.docx (22.5 kB)

Supplementary Material – Patient preferences for frontline therapies for Ph-positive acute lymphoblastic leukemia: a discrete choice experiment

dataset

posted on 2022-02-25, 08:28 authored by Figshare Future Science GroupFigshare Future Science Group, Ashaye, Ajibade, Thomas, Caitlin, Dalal, Mehul, Kota, Vamsi, Krucien, Nicolas, Sae-Hau, Maria, Weiss, Elisa, Campbell, Scott, Marsh, Kevin

Table S1. Comparison of statistical performance across models

Funding

Takeda Development Center Americas, Inc.

History

Usage metrics

Future Oncology

Keywords

acute lymphoblastic leukemia discrete choice experiment hematologic neoplasms patient preference Philadelphia chromosome shared decision making tyrosine kinase inhibitor Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0